Hyphen BioMed recalls
Hyphen BioMed has 5 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 16 May 2018. The most frequent reason is potency & assay.
Total recalls5since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 16 May 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 5 100%Class III 0 0%
Why hyphen biomed is recalled
Product types
By year
All hyphen biomed recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Zymutest HIA MonoStrip IgG recalled by Hyphen BioMed | Hyphen BioMed | Potency & Assay | 5 states |
| Device | CLASS II | Zymutest HIA IgGAM recalled by Hyphen BioMed | Hyphen BioMed | Potency & Assay | 5 states |
| Device | CLASS II | Zymutest HIA MonoStria qualitative screening assay intended recalled | Hyphen BioMed | Potency & Assay | 5 states |
| Device | CLASS II | Zymutest HIA MonoStrip IgGAM recalled by Hyphen BioMed | Hyphen BioMed | Potency & Assay | |
| Device | CLASS II | Zymutest HIA IgGAM recalled by Hyphen BioMed | Hyphen BioMed | Potency & Assay |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.